Patent 11009162

Extensions

Patent term adjustments, term extensions, continuations, divisionals, family members, and expiration dates.

Active provider: Google · gemini-2.5-flash

Extensions

Patent term adjustments, term extensions, continuations, divisionals, family members, and expiration dates.

✓ Generated

To provide a comprehensive overview of US Patent 11009162, including patent term adjustments (PTA), patent term extensions (PTE), continuation/divisional applications, related family members, and projected expiration, I'll leverage the official USPTO data available through their search portals.

Patent Term Adjustment (PTA)

Patent Term Adjustment (PTA) is granted to compensate for delays by the USPTO during the prosecution of a patent application. It is added to the 20-year term of the patent. These delays can include the USPTO failing to:

  • Issue a first Office Action within 14 months of filing.
  • Respond to an applicant's reply within four months.
  • Issue the patent within four months of the issue fee payment.
  • Issue a patent within 36 months of the filing date.

The calculation of PTA also considers any delays caused by the applicant.

For US Patent 11009162, the patent document itself should list the awarded PTA. Without direct access to the specific patent's front page from the USPTO database, I cannot state the exact PTA.

Patent Term Extension (PTE)

Patent Term Extension (PTE) is available for patents claiming products, or methods of using or manufacturing products, that require regulatory approval (e.g., from the FDA) before commercial marketing. This extension aims to restore patent term lost during the regulatory review process. Eligibility requirements include:

  • The patent term has not expired before the PTE application is submitted.
  • The patent term has never been extended under certain provisions.
  • The product was subject to a regulatory review period before commercial marketing or use.

Given that US Patent 11009162 relates to hydraulic fracturing systems, which are generally not subject to FDA or similar regulatory approval processes for drug products, medical devices, or food additives, it is highly unlikely to have received any Patent Term Extension (PTE).

Continuation Applications, Divisional Applications, and Related Family Members

Patent 11009162 has several related applications:

  • US16/728,359: This is the application number for US11009162B1, and it shares the same filing and priority date (2019-12-27). [cite: US11009162B1]
  • ARP200103642A (AR120897A1): This is an Argentine priority application, sharing the same priority date of 2019-12-27. [cite: US11009162B1]
  • US17/321,936 (US11668420B2): This is a continuation application, filed 2021-05-17, claiming priority to 2019-12-27. [cite: US11009162B1]
  • US18/206,313 (US12152711B2): This is another continuation application, filed 2023-06-06, claiming priority to 2019-12-27. [cite: US11009162B1]
  • ARP230102163A (AR130221A2): This is another Argentine priority application, filed 2023-08-15, claiming priority to 2019-12-27. [cite: US11009162B1]

These indicate a family of patents and applications stemming from the initial priority date of December 27, 2019. The two US applications, US17/321,936 and US18/206,313, are continuation applications. Continuation applications are filed after an earlier application (the parent) but before its patenting or abandonment, and claim the benefit of the filing date of the parent.

Projected Expiration Date

The standard term for utility patents issued from applications filed on or after June 8, 1995, is 20 years from the earliest effective filing date, subject to any patent term adjustments or extensions.

For US Patent 11009162, the filing date is December 27, 2019. Therefore, the statutory 20-year term would normally end on December 27, 2039. The patent record explicitly states an "Anticipated expiration" date of 2039-12-27. [cite: US11009162B1]

Unless there are specific PTA days added (which are not available in the provided text), the projected expiration date is December 27, 2039. As previously noted, PTE is highly unlikely for this type of patent.

Generated 5/28/2026, 1:52:05 PM